306
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Which clinical factors and biochemical parameters are associated with late-life major depression?

, , , , , , , , , , , , , , , , & show all
Pages 359-366 | Received 06 Mar 2023, Accepted 11 Sep 2023, Published online: 27 Sep 2023

References

  • Alexopoulos, G. S. (2019). Mechanisms and treatment of late-life depression. Translational Psychiatry, 9(1), 188. doi: 10.1038/s41398-019-0514-6.
  • Altamura, A. C., Buoli, M., Albano, A., & Dell’Osso, B. (2010). Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: A naturalistic study. International Clinical Psychopharmacology, 25(3), 172–179. doi: 10.1097/YIC.0b013e3283384c74.
  • Altamura, A. C., Buoli, M., & Pozzoli, S. (2014). Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: Comparison with schizophrenia. Psychiatry and Clinical Neurosciences, 68(1), 21–36. doi: 10.1111/pcn.12089.
  • American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). American Psychiatric Association.
  • Anttila, S. A., & Leinonen, E. V. (2001). A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Reviews, 7(3), 249–264. doi: 10.1111/j.1527-3458.2001.tb00198.x.
  • Barton, B. B., Zagler, A., Engl, K., Rihs, L., & Musil, R. (2020). Prevalence of obesity, metabolic syndrome, diabetes and risk of cardiovascular disease in a psychiatric inpatient sample: Results of the Metabolism in Psychiatry (MiP) Study. European Archives of Psychiatry and Clinical Neuroscience, 270(5), 597–609. doi: 10.1007/s00406-019-01043-8.
  • Basolo, A., Ando, T., Chang, D. C., Hollstein, T., Krakoff, J., Piaggi, P., & Votruba, S. (2021). Reduced albumin concentration predicts weight gain and higher ad libitum energy intake in humans. Frontiers in Endocrinology, 12, 642568. doi: 10.3389/fendo.2021.642568.
  • Belvederi Murri, M., Amore, M., Menchetti, M., Toni, G., Neviani, F., Cerri, M., Rocchi, M. B., Zocchi, D., Bagnoli, L., Tam, E., Buffa, A., Ferrara, S., Neri, M., Alexopoulos, G. S., & Zanetidou, Safety and Efficacy of Exercise for Depression in Seniors (SEEDS) Study Group. (2015). Physical exercise for late-life major depression. British Journal of Psychiatry: The Journal of Mental Science, 207(3), 235–242. doi: 10.1192/bjp.bp.114.150516.
  • Bengtsson, T., & Scott, K. (2011). Population aging and the future of the welfare state: The example of Sweden. Population and Development Review, 37(Suppl 1), 158–170. doi: 10.1111/j.1728-4457.2011.00382.x.
  • Borroni, E., Pesatori, A. C., Bollati, V., Buoli, M., & Carugno, M. (2022). Air pollution exposure and depression: A comprehensive updated systematic review and meta-analysis. Environmental Pollution (Barking, Essex: 1987), 292(Pt A), 118245. doi: 10.1016/j.envpol.2021.118245.
  • Buoli, M., Caldiroli, L., Guenzani, D., Carnevali, G. S., Cesari, M., Turolo, S., Barkin, J. L., Messa, P., Agostoni, C., & Vettoretti, S, DREAM Project Group (2021). Associations between cholesterol and fatty acid profile on the severity of depression in older persons with nondialysis chronic kidney disease. Journal of Renal Nutrition: The Official Journal of the Council on Renal Nutrition of the National Kidney Foundation, 31(5), 537–540. doi: 10.1053/j.jrn.2020.08.017.
  • Buoli, M., Cesana, B. M., Barkin, J. L., Tacchini, G., & Altamura, A. C. (2018). Validity of a clinical diagnosis of bipolar disorder among participants in a multicenter study using the mini-international neuropsychiatric interview. Bipolar Disorders, 20(3), 284–284. doi: 10.1111/bdi.12635.
  • Buoli, M., Grassi, S., Iodice, S., Carnevali, G. S., Esposito, C. M., Tarantini, L., Barkin, J. L., & Bollati, V. (2019). The role of clock genes in perinatal depression: The light in the darkness. Acta Psychiatrica Scandinavica, 140(4), 382–384. doi: 10.1111/acps.13084.
  • Buoli, M., Ceresa, A., Barkin, J. L., Weston, C., Mucci, F., Pozzoli, S., & Esposito, C. M. (2021). Intravenous augmentative valproate versus delorazepam in bipolar patients with a major depressive mixed episode and partial/nonresponse to oral treatment: A pilot study. Journal of Clinical Psychopharmacology, 41(1), 79–81. doi: 10.1097/JCP.0000000000001314.
  • Buoli, M., Capuzzi, E., Caldiroli, A., Ceresa, A., Esposito, C. M., Posio, C., Auxilia, A. M., Capellazzi, M., Tagliabue, I., Surace, T., Legnani, F., Cirella, L., Di Paolo, M., Nosari, G., Zanelli Quarantini, F., Clerici, M., Colmegna, F., & Dakanalis, A. (2022). Clinical and biological factors are associated with treatment-resistant depression. Behavioral Sciences (Basel, Switzerland), 12(2), 34. doi: 10.3390/bs12020034.
  • Caldiroli, A., Capuzzi, E., Barkin, J. L., Grassi, S., Esposito, C. M., Auxilia, A. M., Russo, S., Tagliabue, I., Carnevali, G. S., Mucci, F., Invernizzi, E., Clerici, M., & Buoli, M. (2022). Is there an association between inflammatory/anti-oxidant markers and the presence of psychotic symptoms or severity of illness in mood and psychotic disorders? A multi-centric study on a drug-free sample. Brain, Behavior, & Immunity – Health, 22, 100453. doi: 10.1016/j.bbih.2022.100453.
  • Cabrerizo, S., Cuadras, D., Gomez-Busto, F., Artaza-Artabe, I., Marín-Ciancas, F., & Malafarina, V. (2015). Serum albumin and health in older people: Review and meta-analysis. Maturitas, 81(1), 17–27. doi: 10.1016/j.maturitas.2015.02.00.
  • Capuzzi, E., Caldiroli, A., Besana, F., Tagliabue, I., Capellazzi, M., Cova, F., Rubelli, P., Sergio, M. R., Truisi, E., Buoli, M., & Clerici, M. (2021). The association between childhood trauma and lifetime suicide attempts among a sample of male prisoners: a pilot observational study. Journal of Forensic and Legal Medicine, 80, 102180. doi: 10.1016/j.jflm.2021.102180.
  • Gabarrell-Pascuet, A., Moneta, M. V., Ayuso-Mateos, J. L., Miret, M., Lara, E., Haro, J. M., Olaya, B., & Domènech-Abella, J. (2022). The effect of loneliness and social support on the course of major depressive disorder among adults aged 50 years and older: a longitudinal study. Depression and Anxiety, 39(2), 147–155. doi: 10.1002/da.23236.
  • Gadzhanova, S., Roughead, E. E., & Pont, L. G. (2018). Antidepressant switching patterns in the elderly. International Psychogeriatrics, 30(9), 1365–1374. doi: 10.1017/S1041610217002964.
  • Gaynes, B. N., Lux, L., Gartlehner, G., Asher, G., Forman-Hoffman, V., Green, J., Boland, E., Weber, R. P., Randolph, C., Bann, C., Coker-Schwimmer, E., Viswanathan, M., & Lohr, K. N. (2020). Defining treatment-resistant depression. Depression and Anxiety, 37(2), 134–145. doi: 10.1002/da.22968.
  • Guenzani, D., Buoli, M., Caldiroli, L., Carnevali, G. S., Serati, M., Vezza, C., Armelloni, S., Messa, P., & Vettoretti, S, DREAM Project Group. (2019). Malnutrition and inflammation are associated with severity of depressive and cognitive symptoms of old patients affected by chronic kidney disease. Journal of Psychosomatic Research, 124, 109783. doi: 10.1016/j.jpsychores.2019.109783.
  • Gutiérrez-Rojas, L., Porras-Segovia, A., Dunne, H., Andrade-González, N., & Cervilla, J. A. (2020). Prevalence and correlates of major depressive disorder: a systematic review. Revista Brasileira de Psiquiatria (Sao Paulo, Brazil : 1999)), 42(6), 657–672. doi: 10.1590/1516-4446-2020-0650.
  • Haroon, E., Daguanno, A. W., Woolwine, B. J., Goldsmith, D. R., Baer, W. M., Wommack, E. C., Felger, J. C., & Miller, A. H. (2018). Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder. Psychoneuroendocrinology, 95, 43–49. doi: 10.1016/j.psyneuen.2018.05.026.
  • Hegeman, J. M., Kok, R. M., van der Mast, R. C., & Giltay, E. J. (2012). Phenomenology of depression in older compared with younger adults: Meta-analysis. British Journal of Psychiatry: The Journal of Mental Science, 200(4), 275–281. doi: 10.1192/bjp.bp.111.095950.
  • Hsu, C. W., Tseng, W. T., Wang, L. J., Yang, Y. H., Kao, H. Y., & Lin, P. Y. (2022). Comparative effectiveness of antidepressants on geriatric depression: Real-world evidence from a population-based study. Journal of Affective Disorders, 296, 609–615. doi: 10.1016/j.jad.2021.10.009.
  • Iodice, S., Ceresa, A., Esposito, C. M., Mucci, F., Conti, D. M., Pergoli, L., Tarantini, L., Vigna, L., Bollati, V., Buoli, M., Serati, M. & Stand-Up Project Group, (2021). The independent role of body mass index (BMI) and severity of depressive symptoms on biological changes of women affected by overweight/obesity. International Journal of Environmental Research and Public Health, 18(6), 2923. doi: 10.3390/ijerph18062923.
  • Jura, M., & Kozak, L. P. (2016). Obesity and related consequences to ageing. Age (Dordrecht, Netherlands), 38(1), 23. doi: 10.1007/s11357-016-9884-3.
  • Keller, J., Gomez, R., Williams, G., Lembke, A., Lazzeroni, L., Murphy, G. M., Jr, & Schatzberg, A. F. (2017). HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Molecular Psychiatry, 22(4), 527–536. doi: 10.1038/mp.2016.120.
  • Khouzam, H. R. (2017). A review of trazodone use in psychiatric and medical conditions. Postgraduate Medicine, 129(1), 140–148. doi: 10.1080/00325481.2017.1249265.
  • Klimova, B., Novotny, M., & Valis, M. (2020). The impact of nutrition and intestinal microbiome on elderly depression – A systematic review. Nutrients, 12(3), 710. doi: 10.3390/nu12030710.
  • Kok, R. M., & Reynolds, C. F. (2017). Management of depression in older adults: A review. JAMA, 317(20), 2114–2122. doi: 10.1001/jama.2017.5706.
  • Krause, M., Gutsmiedl, K., Bighelli, I., Schneider-Thoma, J., Chaimani, A., & Leucht, S. (2019). Efficacy and tolerability of pharmacological and non-pharmacological interventions in older patients with major depressive disorder: A systematic review, pairwise and network meta-analysis. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology, 29(9), 1003–1022. doi: 10.1016/j.euroneuro.2019.07.130.
  • Kuzuya, M., Ando, F., Iguchi, A., & Shimokata, H. (2002). Effect of aging on serum uric acid levels: Longitudinal changes in a large Japanese population group. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 57(10), M660–4. doi: 10.1093/gerona/57.10.m660.
  • Lima, W. G., Martins-Santos, M. E., & Chaves, V. E. (2015). Uric acid as a modulator of glucose and lipid metabolism. Biochimie, 116, 17–23. doi: 10.1016/j.biochi.2015.06.025.
  • Lindqvist, D., Dhabhar, F. S., James, S. J., Hough, C. M., Jain, F. A., Bersani, F. S., Reus, V. I., Verhoeven, J. E., Epel, E. S., Mahan, L., Rosser, R., Wolkowitz, O. M., & Mellon, S. H. (2017). Oxidative stress, inflammation and treatment response in major depression. Psychoneuroendocrinology, 76, 197–205. doi: 10.1016/j.psyneuen.2016.11.031.
  • Marijnissen, R. M., Vogelzangs, N., Mulder, M. E., van den Brink, R. H., Comijs, H. C., & Oude Voshaar, R. C. (2017). Metabolic dysregulation and late-life depression: A prospective study. Psychological Medicine, 47(6), 1041–1052. doi: 10.1017/S0033291716003196.
  • Mulley, G. (2007). Myths of ageing. Clinical Medicine (London, England), 7(1), 68–72. doi: 10.7861/clinmedicine.7-1-68.
  • Ng, A., Tam, W. W., Zhang, M. W., Ho, C. S., Husain, S. F., McIntyre, R. S., & Ho, R. C. (2018). IL-1β, IL-6, TNF-α and CRP in elderly patients with depression or Alzheimer’s disease: Systematic review and meta-analysis. Scientific Reports, 8(1), 12050. doi: 10.1038/s41598-018-30487-6.
  • Okereke, O. I., Lyness, J. M., Lotrich, F. E., & Reynolds, C. F. (2013). Depression in late-life: A focus on prevention. Focus (American Psychiatric Publishing), 11(1), 22–31. doi: 10.1176/appi.focus.11.1.22.
  • Pagliai, G., Sofi, F., Vannetti, F., Caiani, S., Pasquini, G., Molino Lova, R., Cecchi, F., Sorbi, S., & Macchi, C. (2018). Mediterranean diet, food consumption and risk of late-life depression: The Mugello study. Journal of Nutrition, Health & Aging, 22(5), 569–574. doi: 10.1007/s12603-018-1019-3.
  • Patten, S. B. (2015). Psychiatric epidemiology: It is about much more than prevalence. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 60(12), 529–530. doi: 10.1177/070674371506001201.
  • Petkus, A. J., Younan, D., Wang, X., Beavers, D. P., Espeland, M. A., Gatz, M., Gruenewald, T. L., Kaufman, J. D., Chui, H. C., Manson, J. E., Resnick, S. M., Wellenius, G. A., Whitsel, E. A., Widaman, K., & Chen, J. C. (2021). Air pollution and the dynamic association between depressive symptoms and memory in oldest-old women. Journal of the American Geriatrics Society, 69(2), 474–484. doi: 10.1111/jgs.16889.
  • Picton, J. D., Marino, A. B., & Nealy, K. L. (2018). Benzodiazepine use and cognitive decline in the elderly. American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists, 75(1), e6–e12. doi: 10.2146/ajhp160381.
  • Porto, L. G., Nogueira, R. M., Nogueira, E. C., Molina, G. E., Farioli, A., Junqueira, L. F., Jr,., & Kales, S. N. (2016). Agreement between BMI and body fat obesity definitions in a physically active population. Archives of Endocrinology and Metabolism, 60(6), 515–525. doi: 10.1590/2359-3997000000220.
  • Ramklint, M., & Ekselius, L. (2003). Personality traits and personality disorders in early onset versus late onset major depression. Journal of Affective Disorders, 75(1), 35–42. doi: 10.1016/s0165-0327(02)00028-9.
  • Ravari, A., Mirzaei, T., Bahremand, R., Raeisi, M., & Kamiab, Z. (2021). The effect of Pilates exercise on the happiness and depression of elderly women: A clinical trial study. Journal of Sports Medicine and Physical Fitness, 61(1), 131–139. doi: 10.23736/S0022-4707.20.10730-8.
  • Rossom, R. C., Solberg, L. I., Vazquez-Benitez, G., Whitebird, R. R., Crain, A. L., Beck, A., & Unützer, J. (2016). Predictors of poor response to depression treatment in primary care. Psychiatric Services (Washington, D.C.), 67(12), 1362–1367. doi: 10.1176/appi.ps.201400285.
  • Serati, M., Redaelli, M., Buoli, M., & Altamura, A. C. (2016). Perinatal major depression biomarkers: A systematic review. Journal of Affective Disorders, 193, 391–404. doi: 10.1016/j.jad.2016.01.027.
  • Smith, M., Haedtke, C., & Shibley, D. (2015). Late-life depression detection. Journal of Gerontological Nursing, 41(2), 18–25. doi: 10.3928/00989134-20150115-01.
  • Snow, C. E., & Abrams, R. C. (2016). The indirect costs of late-life depression in the United States: A literature review and perspective. Geriatrics (Basel, Switzerland), 1(4), 30. doi: 10.3390/geriatrics1040030.
  • Stevenson, J., Brodaty, H., Boyce, P., & Byth, K. (2012). Does age moderate the effect of personality disorder on coping style in psychiatric inpatients? Journal of Psychiatric Practice, 18(3), 187–198. doi: 10.1097/01.pra.0000415075.20873.0d.
  • Sultana, J., Spina, E., & Trifirò, G. (2015). Antidepressant use in the elderly: The role of pharmacodynamics and pharmacokinetics in drug safety. Expert Opinion on Drug Metabolism & Toxicology, 11(6), 883–892. doi: 10.1517/17425255.2015.1021684.
  • Sun, K., Ren, M., Liu, D., Wang, C., Yang, C., & Yan, L. (2014). Alcohol consumption and risk of metabolic syndrome: A meta-analysis of prospective studies. Clinical Nutrition (Edinburgh, Scotland), 33(4), 596–602. doi: 10.1016/j.clnu.2013.10.003.
  • Taverna, M., Marie, A. L., Mira, J. P., & Guidet, B. (2013). Specific antioxidant properties of human serum albumin. Annals of Intensive Care, 3(1), 4. doi: 10.1186/2110-5820-3-4.
  • Tomasetti, C., Montemitro, C., Fiengo, A. L. C., Santone, C., Orsolini, L., Valchera, A., Carano, A., Pompili, M., Serafini, G., Perna, G., Vellante, F., Martinotti, G., Giannantonio, M. D., Kim, Y. K., Nicola, M. D., Bellomo, A., Ventriglio, A., Fornaro, M., & Berardis, D. D. (2019). Novel pathways in the treatment of major depression: Focus on the glutamatergic system. Current Pharmaceutical Design, 25(4), 381–387. doi: 10.2174/1381612825666190312102444.
  • Ventriglio, A., Bhugra, D., Sampogna, G., Luciano, M., De Berardis, D., Sani, G., & Fiorillo, A. (2020). From dysthymia to treatment-resistant depression: evolution of a psychopathological construct. International Review of Psychiatry (Abingdon, England), 32(5–6), 471–476. doi: 10.1080/09540261.2020.1765517.
  • Voineskos, D., Daskalakis, Z. J., & Blumberger, D. M. (2020). Management of treatment-resistant depression: Challenges and strategies. Neuropsychiatric Disease and Treatment, 16, 221–234. doi: 10.2147/NDT.S198774.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.